Загрузка...
Updates and challenges on treatment with BRAF/MEK-inhibitors in melanoma
INTRODUCTION: Breakthroughs in targeted therapy have significantly improved outcomes for many patients with advanced melanoma, including those with BRAFV600 mutant disease. Targeted therapy for BRAFV600-mutant metastatic melanoma includes combinations of BRAF inhibitors and MEK inhibitors, which imp...
Сохранить в:
| Опубликовано в: : | Expert Opin Orphan Drugs |
|---|---|
| Главные авторы: | , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2018
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6296476/ https://ncbi.nlm.nih.gov/pubmed/30574432 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21678707.2018.1512402 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|